Teresa Beers-Wesolowski

Teresa Beers-Wesolowski serves as a Contract Specialist within the 252-NETWORK Contract Office 12 (36C252) of the Department of Veterans Affairs, where she manages the acquisition of mission-critical medical equipment, pharmaceuticals, and facility infrastructure systems essential to sustaining veteran healthcare delivery. Her role encompasses the full lifecycle of procurement—from market research and solicitation development to contract award and administration—ensuring compliance with federal regulations and alignment with VA’s strategic priorities in modernizing clinical environments. She routinely handles complex procurements involving high-value medical devices, laboratory instrumentation, and specialized pharmaceutical manufacturing services, requiring deep technical understanding and precise contract language to meet clinical and operational standards. Teresa maintains consistent working relationships with key vendors including MCKENZIE CONSTRUCTION & SITE DEVELOPMENT LLC, EXELAN PHARMACEUTICALS INC, KOFFEL MEDICAL SUPPLY INC, ADVANCED IMAGING MANAGEMENT, LLC, and TROOP CONTRACTING INC. These partnerships reflect a focus on suppliers capable of delivering specialized medical supplies, pharmaceutical formulations, diagnostic equipment, and facility upgrades under strict regulatory and quality control frameworks. Her contracting approach emphasizes reliability, technical capability, and performance accountability, fostering long-term vendor collaboration to support continuous healthcare operations. Her procurement activity is exclusively conducted under open, unrestricted competitions, with no set-asides applied to her portfolio. This reflects a strategic emphasis on maximizing competition among qualified vendors rather than socioeconomic set-asides, prioritizing technical fitness and service reliability over socioeconomic classifications. Teresa’s primary procurement focus centers on NAICS codes related to pharmaceutical and biological manufacturing (325412 and 325414), analytical laboratory instrument manufacturing (334516), and in-vitro diagnostic substances (325413), underscoring her expertise in life sciences and clinical diagnostics. She routinely acquires custom-formulated pharmaceuticals, precision lab equipment, and diagnostic reagents, demonstrating specialized knowledge in FDA-regulated supply chains and healthcare technology integration.